>>Description of the research protocol "LORD"

Management of low grade ductal carcinoma in situ (low grade DCIS): a randomized, multicenter, non-inferiority trial, between standard therapy approach versus active surveillance
Status : Ongoing and recruiting

Additional details

Indication (or studied pathology) : Gynecologie : Cancer du Sein IS
Brugmann identifier : LORD
EudraCT identifier : B322201733712
ClinicalTrials.gov identifier : NCT02492607


Involved department : Gynecology-obstetrics
Principal investigator : Nazac
Sponsor : EORTC 1401
Contact : Clinical Research Unit

>This protocol was approved by the KU Leuven ethics committee.